The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical trial in progress: Pivotal study of VB-111 combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).
 
Rebecca Christian Arend
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Pfizer; Tesaro; VBL Therapeutics
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Agenus; Amgen; AstraZeneca; ChemoCare; ChemoID; Clovis Oncology; Conjupro Biotherapeutics; Eisai; Geistlich Pharma; Genmab; Immunogen; Immunomedics; Incyte; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; OncoQuest; Perthera; Pfizer; Precision Oncology; Puma Biotechnology; Roche/Genentech; Samumed; Takeda; Tesaro; VBL Therapeutics
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Cerulean Pharma; ChemoCare; ChemoID; Clovis Oncology; Eisai; Geistlich Pharma; Immunogen; Incyte; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; OncoMed; OncoSec; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Samumed; Takeda; Tesaro; VBL Therapeutics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Robert Allen Burger
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gradalis; Janssen Research & Development; Merck; Morphotek; Tesaro; VBL Therapeutics
Travel, Accommodations, Expenses - Genentech; Tesaro
 
Thomas J. Herzog
Leadership - GOG Partners
Consulting or Advisory Role - AstraZeneca; Caris MPI; Clovis Oncology; GlaxoSmithKline; Johnson & Johnson; Roche/Genentech
 
Jonathan A. Ledermann
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - Artios; AstraZeneca/MedImmune; Clovis Oncology; Cristal Therapeutics; Eisai; Merck; Pfizer; Seagen; Tesaro
Speakers' Bureau - Clovis Oncology; Pfizer; Tesaro/GSK
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
Other Relationship - Regeneron
 
Kathleen N. Moore
Honoraria - Prime Oncology; Research To Practice
Consulting or Advisory Role - Abbvie; Aravive; AstraZeneca (Inst); Clovis Oncology; Eisai; Genentech/Roche; Immunogen; Janssen Oncology; Merck; Mersana (Inst); OncoMed; Pfizer/EMD Serono; Samumed; TESARO (Inst); Vavotar Life Sciences; VBL Therapeutics
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
 
Angeles Alvarez Secord
Honoraria - Aravive; AstraZeneca; Clovis Oncology; Cordgenics; Genentech/Roche; Janssen; Merck; Mersana; Oncoquest; Tesaro
Consulting or Advisory Role - Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Oncoquest; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); Immutep (Inst); Merck (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst)
 
Roni Shapira
Consulting or Advisory Role - VBL Therapeutics
 
Krishnansu Sujata Tewari
Honoraria - Clovis Oncology; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Marilyn Huang
Consulting or Advisory Role - Clovis Oncology; Merck; Tesaro
Research Funding - Merck
 
Amnon Amit
No Relationships to Disclose
 
Tamar Rachmilewitz Minei
Employment - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
 
Dror Harats
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
 
Richard T. Penson
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; Janssen Oncology; Mersana; Newlink Genetics; Sutter Medical Group; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Janssen Oncology; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie